. Differential splicing of HIV-1 RNA generates more than HIV-1 mRNA splicing has also been studied in vivo 30 distinct mono-or bicistronic mRNA species which fall using reverse transcription-initiated polymerase chain reinto three classes: the unspliced (US) full-length 9-kb action (RT-PCR) techniques. Intriguingly, an early study mRNA, partially spliced 4-to 5-kb mRNAs, and the multireported a dramatic overexpression of MS RNA relative ply spliced (MS) Ç2-kb mRNAs (Neumann et al., 1994;  to US mRNA in peripheral blood mononuclear cells Schwartz et al., 1990 Schwartz et al., , 1992 Pavlakis et al., 1991) . US (PBMCs) of most asymptomatic (but not symptomatic) mRNA encodes the Gag and Gag-Pol polyproteins, and subjects, suggesting that clinical latency of HIV infection also serves as the genomic RNA of progeny virions. MS is associated with a ''blocked early-stage'' HIV mRNA mRNAs give rise to the regulatory and accessory HIV splicing pattern, as if the viral life-cycle in these cells proteins Tat, Rev, Nef, Vpr, and Vif. was arrested in an early postintegration step (Seshamma Kinetic analyses of HIV mRNA expression in vitro in et al., 1992) . Although similar results have not been obnewly infected cells (Kim et al., 1989; Klotman et al., 1991;  served in other studies, some recent reports have also Ranki et al., 1994) and in activated latently infected cells suggested that HIV-1 mRNA splicing pattern in PBMC (Michael et al., 1991; Pomerantz et al., 1990) have recould be of clinical significance, and indicated an associvealed a temporal pattern of mRNA splicing consisting ation between a reduced MS/US ratio and a poor prognoof early expression of mostly MS mRNA which changes sis (Furtado et al., 1995; Michael et al., 1995) . during the subsequent 12-48 hr to a predominance of Our longitudinal studies on a large HIV-1-infected co-US mRNA. This process has been attributed to increasing hort have not provided support for this hypothesis. We levels of the Rev protein which binds to US and partially found that while the overall HIV mRNA expression spliced mRNAs containing a Rev-responsive element strongly correlated with prognosis, MS and US mRNAs and is required for efficient accumulation of these were expressed in roughly equimolar ratios in PBMCs mRNAs in the cytoplasm of infected cells (reviewed in of most asymptomatic individuals regardless of the subsequent course of their disease Vesanen et al., 1996) . Similar findings were recently HIV-1 mRNA species during disease progression (Saltar-elli et al., 1996) . Furthermore, in cases when we have onto ice, and combined with a mixture containing: 6 ml 51 reaction buffer (51: 250 mM Tris, pH 8.3; 375 mM found the MS/US ratio to significantly deviate from 1:1, no association with a particular future disease pattern KCl, 15 mM MgCl 2 ), 1.5 ml dNTPs 10 mM each, 0.6 ml RNasin, 1 ml random hexamers (1 mM, Pharmacia), and has been observed. Similar to the studies by Michael et al. and Furtado et al., however, we (Saksela et al., 1994;  2 ml M-MLV-reverse transcriptase (200U/ml; Gibco-BRL) and incubated for 1 hr at 42Њ. Vesanen et al., 1996) and others (Saltarelli et al., 1996) have noticed a relative loss of MS mRNA in PBMCs of Amplification of US HIV-1 mRNA some individuals upon development of CD4/ T lymphopenia. The underlying causes of such aberrant HIV Two-microliters of random-primed PBMC cDNA was mRNA splicing patterns are yet to be elucidated.
added into each 50 ml PCR reaction containing 10 mM Recent studies on patients treated with novel potent Tris, pH 8.5, 50 mM KCl, 1.0 mM MgCl 2 , 0.02% gelatin, antiretroviral drugs have shown that the viral load in 50 mM of each unlabeled dNTPs, 150 ng each oligonucleplasma of infected individuals is determined by a highly otide primer, 0.25 ml a[ 32 P]dCTP (NEN, 3000 Ci/mmol), dynamic equilibrium between HIV production and clearand 0.25 ml Taq-polymerase (5 U/ml; Boehringer Mannance (Ho et al., 1995; Wei et al., 1995) . Moreover, it has heim). These reactions were cycled for 31 rounds bebeen shown that the rapid decline in plasma viremia tween 94 (40 sec) and 69Њ (1 min) using Perkin-Elmer results from the decay of two components: removal of GeneAmp PCR system 9600. The primers used for US productively infected cells (T1/2 Ç 1.6 days) and clear-HIV-1 mRNA amplification were: 5-TCT CTA GCA GTG ance of cell-free virus (T1/2 Ç 6 hr) (Perelson et al., 1996) .
GCG CCC GAA CA-3 (sense) and 5-TCT CCT TCT AGC Thus, it can be concluded that approximately half of the CTC CGC TAG TC-3 (antisense) giving rise to a 160-productively infected PBMCs at any given time have bebp product. This assay detects full-length HIV-1 mRNA come infected as recently as during the preceding 2 encoding Gag and Gag-Pol proteins as well as genomic days.
HIV RNA. Therefore, assuming that the temporal changes in HIV mRNA splicing pattern that occur in vivo are similar to Amplification of MS HIV-1 mRNA those seen in vitro (Kim et al., 1989; Klotman et al., 1991;  MS HIV-1 mRNA was amplified using a nested PCR Michael et al., 1991; Pomerantz et al., 1990; Ranki et strategy. Both rounds of amplification were done using al., 1994), it is predicted that in a steady-state situation, the same reaction conditions as described for US mRNA expression of viral MS mRNA relative to US mRNA would and utilized a common antisense primer: 5-TTC CTT be determined by the proportion of recently infected cells CGG GCC TGT CGG GTC GG-3. The sequence of the among all circulating productively infected cells, and that outer sense MS primer was 5-CTT AGG CAT CTC CTA blocking infection of new cells by potent antivirals should TGG CAG GAA-3, and the inner one was 5-TCC TAT result in a rapid decrease in the MS/US mRNA ratio.
GGC AGG AAG AAG CGG AG-3 (resulting in fragments The present results provide experimental data to directly of 131 and 121 bp). After the first round of amplification support this scenario, thereby further substantiating the consisting of 25 cycles, 5 ml of this reaction was added notion of a rapid turnover of productively infected cells into triplicate nested reactions which were cycled 11, 17, in vivo, and clarifying the constitution of HIV-1 mRNA or 22 rounds. The secondary reaction in which the signal splicing patterns observed in HIV-infected persons.
was in the optimal linear range of amplification (as compared to a standard dilution curve) was subsequently MATERIALS AND METHODS used to estimate MS HIV mRNA copy-number in the specimen (see below). This assay detects small HIV-1 Nucleic acid preparation mRNAs giving rise to Tat, Vif, Vpr, Rev, and Nef proteins. Total cellular RNA and DNA were extracted from PBMC specimens using TRI Reagent (Molecular ReAmplification of GAPDH mRNA search Center, Inc., Cincinnati, OH) according to the inTo monitor the recovery of intact PBMC RNA from difstructions from the supplier. Additionally, isolated RNA ferent PBMC specimens and the uniform efficiency of preparations were treated for 1 hr with 100 U of RNaseeach reverse transcription reaction, a 189-bp glyceraldefree DNase (Boehringer Mannheim) in the presence of 50 hyde-3-phosphate dehydrogenase (GAPDH) mRNA-spe-U of placental RNase inhibitor (Boehringer Mannheim), cific fragment was also amplified from each randomextracted with phenol-chloroform, and precipitated with primed cDNA preparation. These reactions were cycled ethanol.
for 20 rounds between 94 (1 min) and 67Њ (2 min) with conditions otherwise as described above, and utilized cDNA synthesis the primers 5-TGG TAT CGT GGA AGG ACT CAT GAC-3 (sense) and 5-ATG CCA GTG AGC TTC CCG TTC Two micrograms of total DNase-treated PBMC RNA in 20 ml of water was heated for 5 min at 80Њ, transferred AGC-3 (antisense).
Controls, RNA standards and quantitation of well with our earlier observations on some AZT-treated patients et al. (1996) . Each set of reverse transcription reactions included a
The observed change in MS/US ratio was caused by control tube with no RNA which was subsequently used the considerably smaller reduction in the expression of for US-and MS-specific PCR reactions as a control for US mRNA as compared to MS mRNA. In fact, in some lack of contamination. In addition, every set of experipatients little or no decrease in US mRNA was observed ments included a control RNA from PBMCs of an HIVat 1 week after treatment, although a significant drop in negative donor. To provide standards for quantitation of plasma viremia was evident in all patients at this point the absolute HIV mRNA copy-numbers in the specimens, (Table 1) . This observation may reflect the trafficking of all experiments also included a panel of 10 PBMC RNAs lymphocytes (infected or not) from tissues into the circuwith twofold serial dilutions of in vitro-transcribed US and lation or could also be due to HIV genomic RNA associ-MS RNA templates ranging from ated with uninfected or nonproductively infected PBMCs 64 to 100,000 copies/mg of HIV-negative PBMC RNA. Ten (see Discussion). microliters of each PCR reaction was analyzed by elec-A week of effective antiretroviral therapy (Table 1) can trophoresis in 8% acrylamide:bisacrylamide (19:1) gels be expected to cause a significant decrease in the relain 11 TBE (90 mM Tris-borate, 1 mM EDTA), and the tive number of cells which have been infected during the intensities of the radiolabeled amplification products in preceding few days. In light of available kinetic data from the dried gels were quantitated using a PhosphorImager studies in cell culture, the observed shift in HIV mRNA (Molecular Dynamics, Inc., Sunnyvale, CA). The specific splicing pattern after therapy therefore suggests that in signals corresponding to the US and MS HIV mRNAa steady-state situation, this pattern directly reflects the specific fragments (the value from an identical area proportion of cells infected at various times before the above the specific amplification signal in each lane was analysis. The change in the HIV mRNA splicing pattern subtracted) were normalized based on the specific from the early MS mRNA-predominated pattern to the GAPDH amplification signals from the same cDNA prepsubsequent relative overexpression of US mRNA takes arations, and used to calculate the absolute HIV mRNA place within 12-48 hr of infection in vitro. To examine copy-numbers in the specimens by comparing these sigthe kinetics of the splicing shift induced by antiretroviral nals with those of the HIV RNA standards analyzed in therapy in vivo, HIV mRNA expression after initiation of parallel. In addition, every assay included an aliquot of a drug therapy was analyzed in greater detail in two pacommon HIV-infected PBMC preparation. The interassay tients (105 and 1302) from whom frequently collected variation in the derived mRNA copy-numbers from re-PBMC specimens were available. peated analyses of this specimen was less than 25%.
Expression of HIV US and MS mRNA in PBMCs colThreshold of linear amplification of unspliced (US) and lected from these two patients before treatment and at multiply spliced (MS) HIV-1 mRNAs is Ç100 copies per every 6-12 hr during the first 3 days of therapy is shown microgram of total PBMC RNA.
in Fig. 2 . In both cases, a substantial decrease in the expression of MS mRNA was observed during this pe-RESULTS riod, with much of this reduction occurring between 12 and 48 hr after initiation of therapy (from 4271/mg to 651/ Paired PBMC samples collected before and 1 week after treatment with a HIV protease inhibitor or combinamg in 105, and from 2701/mg to 823/mg in 1302). By contrast, no apparent decrease in HIV US mRNA was obtion therapy were selected from nine patients involved in published and ongoing studies on dynamics of HIV-1 served during this period. These results are in good agreement with kinetic data on HIV mRNA splicing during infection and efficacy of antiviral therapies (Perelson et al., 1996;  Table 1 ). Total RNA was extracted from PBMCs viral life-cycle in vitro (Kim et al., 1989; Klotman et al., 1991; Michael et al., 1991; Pomerantz et al., 1990) and and subjected to quantitative RT-PCR to measure the expression of US and MS mRNAs as described under thus suggest that the marked reduction in HIV MS mRNA expression in vivo following administration of potent antiMaterials and Methods. Figure 1 shows the absolute copy-numbers of US and MS mRNAs (per mg of PBMC viral drugs is due to a rapidly developing loss of cells in an early postintegration phase of HIV life-cycle. RNA) in these specimens, and also displays as a bar diagram the ratio of MS/US mRNA in each patient before and after 7 days of drug therapy. As can be seen, regard-DISCUSSION less of the overall level of HIV mRNA expression, in each case a significant change in MS/US ratio was observed,
The availability of novel potent antiretroviral drugs have enabled us to perform an analysis of HIV mRNA such that this ratio decreased on average to 34% of its pretreatment value. These results suggest that a change expression akin to an in vivo ''pulse-chase experiment.'' As predicted by in vitro studies on the regulation of HIV in HIV mRNA splicing pattern is a consistent consequence of potent antiretroviral drug therapy and agree mRNA splicing during viral life-cycle (Kim et al., 1989 ; Ranki et al., 1994) , as well as recent insights into the dynamics of HIV infection in vivo (Ho et al., 1995;  Curiously, in some patients (such as 105) US HIV mRNA decreased slower than what one would expect Perelson et al., 1996; Wei et al., 1995) , a rapid change in HIV mRNA splicing was observed in the drug-treated based on the drop in their plasma viral loads. As mentioned above, it could be that upon decreasing viral load patients. These data suggest that the early loss in MS mRNA is caused by a change from an early-stage to a in the body, more lymphocytes (including infected cells
The absolute copy numbers of HIV-1 unspliced (US) and multiply spliced (MS) mRNAs (per microgram of total PBMC RNA) and a bar diagram of their ratio before and 7 days after the therapy in each of the nine study subjects.
FIG. 2.
Dynamics of HIV-1 splicing pattern in two study subjects during the first 3 days of therapy. Their PBMC HIV-1 unspliced (US; *ii/home2/ milesgrsym/8point/gs170,l(3,0) and multiply spliced ii/home2/milesgrsym/8point/gs172,l(3,0) mRNA expression is shown as copies per microgram of total cellular RNA on a log scale. The MS/US mRNA ratio is presented at 12-hr intervals. (0) Not detected.
with a late-stage mRNA splicing pattern) enter the circuuli, as reported after influenza vaccination (O'Brien et al., 1995; Staprans et al., 1995) or IL-2 administration (Kovacs lation thus providing an additional source of US mRNA. However, and alternative explanation for this observation et al., 1995) could result in an increase of cells which are in an early phase of infection, manifesting as a relative could be that the decay of US mRNA might be partially masked by the presence of genomic HIV RNA in the overexpression of MS mRNA. On the other hand, it is possible that when HIV infection is spreading relatively PBMC RNA preparations. Such ''treatment-resistant'' genomic RNA could be derived from viral particles stuck to unimpeded, as might be the case in severely immunodeficient patients, many more susceptible CD4/ cells are the surface of PBMCs and survived through the fractionation and washing of these cells. More interestingly (and already infected, resulting in a fewer number of newly infected cells and thus a relative overexpression of US perhaps more likely) significant numbers of HIV genomes mRNA. However, although such factors could cause almight be present in resting T cells as preintegration comterations in the HIV mRNA splicing pattern, our data do plexes frozen in the viral life-cycle between entry and not support a hypothesis that differential splicing would integration (Bukrinsky et al., 1991; Chun et al., 1995; Ste- be an actively regulated process involved in determining venson et al., 1990; Zack et al., 1990) . Although such the productivity of HIV-infection and the rate of disease ''preintegration latency'' is probably relatively short-lived, progression. it could give rise to an artifactually slow decay rate of
The present results suggest that examination of HIV US mRNA in the present analysis. However, such unac-MS/US mRNA ratio as an indicator of population dynamcounted sources of US HIV mRNA signal (if they exist in ics of HIV-infected cells in vivo could be useful. By providsignificant amounts) are not likely to challenge the presing an almost instantaneous measure of the acute antivient conclusions which are based on the prominent fall ral potency of a drug regimen, monitoring of the early in MS HIV mRNA levels occurring during the first 48 hr decrease in MS HIV mRNA expression might be used of therapy without any accompanying decrease in the as an additional molecular virological tool in developing expression of US HIV mRNA.
and optimizing pharmacological agents to block HIV inBesides supporting the current dynamic model of HIV fection. In addition, more detailed analyses of the expresinfection (Ho et al., 1995; Perelson et al., 1996;  Wei et sion of differentially spliced HIV mRNAs in PBMCs and al., 1995) vation of viral replication by environmental or other stim-
